London, UK, Research Triangle Park, NC & Santa Clara, CA - GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administ… Read »
London, UK, Research Triangle Park, NC & Santa Clara, CA - GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administ… Read »
Frost & Sullivan today announced that the 2008 European Technology Innovation of the Year Award in molecular/cellular imaging has been bestowed upon Aposense Ltd., for its pioneering molecular platfor… Read »
Heerlen, NL - Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the opening of its DSM China Campus in the Zhangjiang Hi-Tech Pa… Read »
WILEX to acquire UCB’s preclinical oncology portfolio of five programmes - Joint development strategy includes buyback options for UCB - UCB to become a strategic investor in WILEX - - Munich, Germ… Read »
WHITEHOUSE STATION, N.J. - Merck & Co., Inc. announced today that the U.S. Food and Drug Administration has issued a second complete response letter regarding the supplemental biologics license applic… Read »
Leiden, The Netherlands - Dutch biopharmaceutical company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today confirms that it is in friendly discussions with Wyeth that may lead to a com… Read »
HHS Secretary Mike Leavitt, Assistant Secretary for Health Admiral Joxel Garcia and HHS Food and Drug Administration (FDA) Commissioner Andrew von Eschenbach, M.D., are in Costa Rica today to mark the… Read »
Creative Forms ZiiLABS and Ushers in the Era of StemCell Computing™ Where Nano-Sized Super Computing Will Be Available in Our Daily Lives through Flexible, Tiny, Powerful and Scalable SoC - - SINGAPORE… Read »
Neuherberg, Obesity is known to increase the risk of chronic disorders, such as diabetes (type 2). An international team of scientists with German participation through the Helmholtz Zentrum Munchen i… Read »
Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that further research is … Read »
| ||||||||||||||||